A Pharmacokinetic Study of Baricitinib in Participants With Liver Disease

Clinical trial NCT01870388 · COMPLETED

Trial details

NCT number: NCT01870388
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Liver Diseases Hepatic Insufficiency

Start date: 2013-06-01
Primary completion: 2013-07-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.